09-12-2025 17:22 via drugs.com

ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy

TUESDAY, Dec. 9, 2025-- There is no clear evidence of harm for women receiving hydroxyurea (HU) during pregnancy for sickle cell disease, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6...
Read more »

Pharmaceutical Industry news



Socioeconomic Factors, Comorbidities Tied to Late-Onset Depression in Long-Term Cancer Survivors
Downstream Harms of Gabapentinoid-Diuretic Prescribing Cascade Often Overlooked
AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout
FDA Approves Expanded Indication for Jaypirca
ASH: Agent Orange Exposure Linked to Increased Risk for Myelodysplastic Syndrome
ASH: Lifestyle Intervention Feasible During Chemo for Lymphoma
ASH: Few Sickle Cell ED Visits Adhere to Guidelines for Opioid Pain Meds
Prepregnancy Eating Disorders Linked to Wheezing, Asthma in Offspring
AES: Antiseizure Medication Failure Elevated for Those With Epilepsy, Depression
Increase in Pediatric Obesity Seen From Before to During Pandemic
Anxiety, Confusion Reported After Notification About Dense Breasts
Cannabis-Linked ED Visits Increased With Exposure to Cannabis Retail Stores
Lung Cancer Screening Rates Improved With Targeting Mammography Participants
2017 to 2023 Saw Decrease in Family Doctors Practicing in Rural Areas
Desktop versie